Firas Al-Zubaydi

Breast intraductal nanoformulations for treating ductal carcinoma in situ I: Exploring metal-ion complexation to slow ciclopirox release, enhance mammary persistence and efficacy.

S. Love, P. Sinko, Dipti Kakkar, 2020, Journal of controlled release : official journal of the Controlled Release Society.

Breast intraductal nanoformulations for treating ductal carcinoma in situ II: Dose de-escalation using a slow releasing/slow bioconverting prodrug strategy

S. Love, P. Sinko, Dipti Kakkar, 2021, Drug Delivery and Translational Research.

Breast intraductal nanoformulations for treating ductal carcinoma in situ II: Dose de-escalation using a slow releasing/slow bioconverting prodrug strategy

S. Love, P. Sinko, Dipti Kakkar, 2021, Drug delivery and translational research.

Evaluation of intraductal delivery of poly(ethylene glycol)‐doxorubicin conjugate nanocarriers for the treatment of ductal carcinoma in situ (DCIS)‐like lesions in rats

S. Love, P. Sinko, Z. Székely, 2018, Journal of interdisciplinary nanomedicine.

The effect of size and polymer architecture of doxorubicin–poly(ethylene) glycol conjugate nanocarriers on breast duct retention, potency and toxicity

S. Love, P. Sinko, Y. Singh, 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.